There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on MDxHealth S.A. Sponsored ADR (MDXH – Research Report) and Morphic Holding (MORF – Research Report) with bullish sentiments.
MDxHealth S.A. Sponsored ADR (MDXH)
BTIG analyst Mark Massaro reiterated a Buy rating on MDxHealth S.A. Sponsored ADR on August 3 and set a price target of $13.00. The company’s shares closed last Thursday at $7.85.
According to TipRanks.com, Massaro is a 3-star analyst with an average return of
MDxHealth S.A. Sponsored ADR has an analyst consensus of Moderate Buy, with a price target consensus of $15.50.
Morphic Holding (MORF)
BTIG analyst Julian Harrison maintained a Buy rating on Morphic Holding on August 3 and set a price target of $64.00. The company’s shares closed last Thursday at $31.93.
According to TipRanks.com, Harrison has currently 0 stars on a ranking scale of 0-5 stars, with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Morphic Holding with a $64.09 average price target, which is a 120.2% upside from current levels. In a report issued on July 20, SVB Securities also initiated coverage with a Buy rating on the stock with a $45.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on MDXH:
- Oppenheimer Sticks to Its Hold Rating for BigCommerce Holdings (BIGC)
- Iovance Biotherapeutics (IOVA) Receives a Buy from Mizuho Securities
- Stifel Nicolaus Sticks to Its Hold Rating for Shake Shack (SHAK)
- Papa John’s International (PZZA) Gets a Buy Rating from Stifel Nicolaus
- Aeva Technologies (AEVA) Gets a Buy Rating from Robert W. Baird